Home >> Marketplace Directory >> M. pneumoniae molecular test, 7/13:108

M. pneumoniae molecular test, 7/13:108

image_pdfCreate PDF

Meridian Bioscience has received FDA clearance for its Mycoplasma pneumoniae molecular diagnostic test on the Illumigene platform.
By amplifying the specific DNA for the detection of M. pneumoniae, the test provides a definitive result, thus helping to ensure that patients receive the appropriate antibiotic therapy in a timely manner.

The test uses throat and nasopharyngeal swab samples, and the procedure is simple and highly sensitive, allowing the flexibility of multiple specimen types. It takes less than one hour.


Meridian Bioscience
, 513-271-3700

CAP TODAY
X